Business
AstraZeneca vaccine volunteer developed spinal inflammation & ‘rare neurological condition’ after two doses – report – RT
A British participant in AstraZeneca’s coronavirus vaccine trial was diagnosed with a serious neurological disorder weeks after her second dose of the inoculation, an internal company document shows.
A previously healthy 37-year-old woman was hospitalized this month after receiving two injections of the pharmaceutical giant’s new vaccine, where it was determined she developed transverse myelitis, a rare neurological ailment caused by inflammation of the spine, according to an internal AstraZeneca safety report obtained by CNN.
Though the report states the woman, who has not been identified by name, had no adverse reaction after her first dose in early June, she began to experience neurologi…
-
General19 hours agoYoung boy flown to Brisbane hospital after K’gari dingo attack
-
General17 hours agoBritish and US planes fly 12-hour mission to patrol Russian border
-
Noosa News20 hours agoWarm weather could make way for rain with ‘damaging winds, large hail’
-
General5 hours agoByford rail extension opening marks final stage of Perth Metronet